Open AccessAnti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study
Author(s) -
Norio Okada,
Shintaro Iwama,
Takayuki Okuji,
Tomoko Kobayashi,
Yoshinori Yasuda,
Eri Wada,
Takeshi Onoue,
Motomitsu Goto,
Mariko Sugiyama,
Taku Tsunekawa,
Hiroshi Takagi,
Daisuke Hagiwara,
Yoshihiro Ito,
Hidetaka Suga,
Ryoichi Banno,
Takashi Hase,
Masahiro Morise,
Mitsuro Kanda,
Kenji Yokota,
Naozumi Hashimoto,
Masahiko Ando,
Yasushi Fujimoto,
Masato Nagino,
Yasuhiro Kodera,
Mitsuhiro Fujishiro,
Hideharu Hibi,
Michihiko Sone,
Hitoshi Kiyoi,
Momokazu Gotoh,
Yuichi Ando,
Masashi Akiyama,
Yoshinori Hasegawa,
Hiroshi Arima
Publication year - 2020
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/s41416-020-0736-7
Subject(s) - medicine , thyroid , anti thyroid autoantibodies , thyroiditis , antibody , thyroid dysfunction , thyroid function , incidence (geometry) , endocrinology , gastroenterology , pathology , autoantibody , immunology , physics , optics
Anti-programmed cell death-1 (PD-1) antibodies can cause thyroid dysfunction. However, no predictive biomarkers enabling stratification of thyroid dysfunction risk have been identified.